Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 61 publications.

Yee K, Poulos C, Bussberg C, Myers K. Patient characteristics associated with treatment preference for generalized Myasthenia Gravis (gMG): a multivariate analysis. Poster to be given at the ISPOR Europe 2024; November 17, 2025. Barcelona, Spain. [abstract] Value Health. 2024 Dec; 27(12 Suppl):S524-5.

La E, Sweeney C, Davenport E, Bunniran S. Work loss associated with adult vaccinations in pharmacy and healthcare professional office settings in the United States. Poster presented at the ISPOR 2024; May 8, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S138. doi: 10.1016/j.jval.2024.03.738

Poulos C, McMichael A, Kent C, Rudin D, Buck P, Ghaswalla P, Mehta D. Healthcare provider preferences for attributes of influenza vaccines in the United States: results from a discrete-choice experiment study. Poster presented at the ISPOR 2024; May 8, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S338. doi: 10.1016/j.jval.2024.03.2106

Poulos C, McMichael A, Kent C, Rudin D, Buck P, Ghaswalla P, Mehta D. Preferences for a combination influenza and COVID-19 vaccine: results from a threshold technique study with consumers in the United Kingdom. Poster presented at the ISPOR 2024; May 7, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S329. doi: 10.1016/j.jval.2024.03.2055

Bonner C, Pilar M, Jacobs S, Samsell B, Hollis K. Optimizing drug value and access using implementation science. Poster presented at the ISPOR 2024; May 7, 2024. Atlanta, GA. [abstract] Value Health. 2024 Jun; 27(6 Supplement):S318. doi: 10.1016/j.jval.2024.03.2000

Poulos C, Leach CA, Kent C, Rudin D, Buck P, Ghaswalla P. Consumer preferences for attributes of influenza vaccines in the United States: results from a discrete-choice experiment study. Poster presented at the ISPOR Europe 2023; November 13, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S457. doi: 10.1016/j.jval.2023.09.2486

Boeri M, Marcek T, Chintakayala PK, Poulos C, Francis A, Langevin E, Balogh O, Petigara T, O’Connor J, Samant S. Preferences of nurses for attributes of pediatric hexavalent vaccines in the United Kingdom. Poster presented at the ISPOR Europe 2023; November 14, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S313. doi: 10.1016/j.jval.2023.09.1653

Calhoun S, Kutikova L, Hollis KA, Helme K, Miller A, Schwarz TF. A novel approach to capturing real-world reasons behind use and satisfaction of NVX-CoV2373 booster use among German adults: direct-to-patient enrollment. Poster presented at the ISPOR Europe 2023; November 14, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S490. doi: 10.1016/j.jval.2023.09.2649

Samant S, Oberle S, Marcek T, Poulos C, Chintakayala PK, Langevin E, Petigara T, Boeri M. Preferences of healthcare providers in Switzerland for attributes of pediatric hexavalent vaccines. Poster presented at the ISPOR Europe 2023; November 15, 2023. Copenhagen, Denmark. [abstract] Value Health. 2023 Dec; 26(12 Supplement):S318-9. doi: 10.1016/j.jval.2023.09.1679

Poulos C, Gebben D, Peay H, Saha A, Vaezy S, Pierce A, Pina I, Farb A, Moultrie R, Babalola O, Tarver ME. Benefit-risk preferences of patients for the use of artificial intelligence and ultrasound imaging in different settings in echocardiography. Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S349. doi: 10.1016/j.jval.2023.03.2378

Poulos C, Pierce A, Chintakayala PK. A review of the influence of stakeholder preference research on the EtR framework. Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S347. doi: 10.1016/j.jval.2023.03.2370

McMichael A, Poulos C, Vass C, Boeri M. A literature review assessing the most common attributes used in stated-preference studies assessing influenza vaccination: do we know what health care professionals value? Poster presented at the ISPOR 2023 Conference; May 7, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S329-30. doi: 10.1016/j.jval.2023.03.1876

Sluga-O'Callaghan M, Derrien Ansquer V, Frugier G, Houghton K. Evaluation of national approvals and data-collection durations in retrospective noninterventional medical record review studies conducted in the United States, Canada, Europe, and Asia. Poster presented at the ISPOR Europe 2022; November 6, 2022. Vienna, Austria. [abstract] Value Health. 2022 Dec 1; 25(12):S488-9. doi: 10.1016/j.jval.2022.09.2424

Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Hellem Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I. Patient preferences for multiple myeloma treatment: a stated preference survey using discrete choice experiment and swing weighting. Poster presented at the ISPOR 2022 Conference; May 15, 2022. National Harbor, MD. [abstract] Value Health. 2022 Jul; 25(7):S298. doi: 10.1016/j.jval.2022.04.069

Poulos C, Ng X, Mansfield C, Rosenberg S, Peay H, Lee J, Irony T, Ho M. Logical soundness in a discrete choice experiment study of benefit risk preferences. Presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Vass CM, Boeri M, Karim S, Marshall D, Craig B, Ho KA, Mott D, Ngorsuraches S, Badawy SM, Mühlbacher A, Gonzalez JM, Heidenreich S. Accounting for preference heterogeneity in discrete-choice experiments: an ISPOR Special Interest Group Report. Value Health. 2022 May;25(5):685-94.

Dorgali MV, Longo A, Vass C, Shields G, Harrison R, Boeri M. Exploring Antimicrobial Resistance (AMR) from a societal perspective: preferences and welfare impacts in the United Kingdom. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Vass C, Rigby D, Payne K. Watching ME watching you: understanding the effect of experimental setting on stated preferences. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Myers K, Klein K, Mansfield C, Poulos C. A review of the use of comprehension questions in health preference studies. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S319-20. doi: 10.1016/j.jval.2020.04.1189

Vass C, Boeri M, Poulos C. Association between access device and stated preferences for health care. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1;. doi: 10.1016/j.jval.2020.04.1183

Poulos C, Vass C, Klein K, Boeri M. Scope tests in health care discrete choice experiments. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S320. doi: 10.1016/j.jval.2020.04.094

Poulos C, Hauber B, Mirzaei F, Dilley A, DeMuro C, Fillit HM. A study of preferences for disease-modifying treatments for Alzheimer's Disease. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S278. doi: 10.1016/j.jval.2020.04.991

Pearce AM, Mulhern BJ, Watson V, Viney RC. How are debriefing questions used in health discrete choice experiments? An online survey. Value Health. 2020 Mar;23(3):289-93. doi: 10.1016/j.jval.2019.10.001

Mansfield C, Poulos C, Boeri M, Hauber B. Performance of a comprehension question in discrete-choice experiment surveys (DCE). Poster presented at the ISPOR 2019 European Conference; November 5, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(S3).

Richardson D, Zhan L, Reynolds M, Odom D, McRoy L, Mitra D, Zelnak A, Jones C. Virtual community engagement among women receiving palbociclib for HR+/ HER2- metastatic breast cancer: data from the Madeline study. Poster presented at the ISPOR 2019 European Conference; November 4, 2019. Copenhagen, Denmark. [abstract] Value Health. 2019 Dec; 22(SE).

Poulos C, Soliman AM, Renz CL, Posner J, Agarwal SK. Patient preferences for endometriosis pain treatments in the United States. Value Health. 2019 Jun;22(6):728-38. doi: 10.1016/j.jval.2018.12.010

Vass C, Ulph F, Georgsson S. Preferences for prenatal and new born screening- a systematic review of discrete choice experiments. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(3):S275.

John NM, Gavan S, Vass CM. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(3):S253. doi: 10.1016/j.jval.2018.09.1513

Levine CA, Ansquer V, Kurosky SK. Evaluation of data collection duration in retrospective noninterventional medical record review oncology studies conducted in the United States (US), Canada, United Kingdom (UK), Germany, France and Spain. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(Suppl 3):S373. doi: 10.1016/j.jval.2018.09.2225

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Observational studies collecting patient preferences and experiences: regulatory differences across countries in Europe. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(Suppl 3):S89. doi: 10.1016/j.jval.2018.09.526

Soekhai V, de Bekker-Grob EW, Ellis AR, Vass C. Discrete choice experiments in health economics: past, present and future. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(3):S325. doi: 10.1016/j.jval.2018.09.1943

Vass CM, Ulph F, Georgsson S. Preferences for antenatal and neonatal screening: a systematic review of discrete choice experiments. Poster presented at the 2018 ISPOR 21st Annual European Congress; November 2018. Barcelona, Spain. [abstract] Value Health. 2018 Oct; 21(S3).

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Evolution of regulatory requirements for retrospective observational studies using medical records in Austria, Belgium, Italy, Netherlands and Switzerland. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl 1):S51. doi: 10.1016/j.jval.2018.04.425

Levine C, Ansquer V, Kurosky SK. Factors associated with data collection duration and participation rates in retrospective noninterventional medical record review studies. Poster presented at the 2018 ISPOR 23rd Annual International Meeting; May 21, 2018. Baltimore, MD. [abstract] Value Health. 2018 May; 21(Suppl):S219. doi: 10.1016/j.jval.2018.04.1485

Vass C, Rigby D, Payne K. Investigating the heterogeneity in women's preferences for breast screening: does the communication of risk matter? Value Health. 2018 Feb;21(2018):219-28. doi: 10.1016/j.jval.2017.07.010

Sluga-O'Callaghan M, Ansquer V, Frugier G, Mai C. Regulatory requirements for non-interventional studies collecting patient preferences and experiences in France, Germany and the UK. Poster presented at the 2017 ISPOR 20th Annual European Congress; November 2017. Glasgow, Scotland. [abstract] Value Health. 2017 Oct; 20(9):A707.

Sluga-O'Callaghan M, Derrien Ansquer V, Mai C. Evolution of regulatory requirements for retrospective observational studies using medical records in France, Germany, Spain and the UK. Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(2017):A68.

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for vaccines against travel-related illnesses. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419-20.

Poulos C, Standaert B, Sloesen B, Hauber AB. What motivates mothers to pay for a vaccine against children's diarrhea? Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419.

Balp M, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Hollis K, Khalil S, Knulst A, Lacour J, Lynde C, Marsland A, Maurer M, McBride D, Nakonechna A, Ortiz De Frutoz FJ, Oude Elberink J, Proctor C, Sussman G, Weller K, Grattan C. Comparison of direct healthcare costs associated with chronic spontaneous/idiopathic urticaria in 7 countries - results from the ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A565.

Wheeler A, Sacco P, Rakhit A, Cabo R. Identifying the unmet medical need of Angelman Syndrome: results of a targeted literature review. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A579.

Hollis K, Abuzakouk M, Balp M, Berard F, Canonica GW, Gimenez-Arnau A, Grattan C, Khalil S, Knulst AC, Lacour J, Lynde C, Maurer M, McBride D, Nakonechna A, Ortiz De Frutos J, Oude Elberink J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Marsland A. Assessing health-utility values for chronic spontaneous/idiopathic urticaria in real-world using the EQ-5D: results from ASSURE-CSU study. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A570-1.

Poulos C. A review of discrete choice experiment studies of preferences for vaccine features. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A220.

Poulos C, Johnson FR, Krishnarajah F, Anonychuk A, Misurski D. Pediatricians' preferences for infant meningococcal vaccination. Value Health. 2015 Jan;18(1):67-77. doi: 10.1016/j.jval.2014.10.010

Vass CM, Rigby D, Campbell S, Payne K. Investigating the framing-effects of risk attributes in discrete choice experiments: a pilot study. Poster presented at the 2014 ISPOR 17th Annual European Congress; November 2014. Amsterdam, The Netherlands. [abstract] Value Health. 2014 Nov; 17(7):A648. doi: 10.1016/j.jval.2014.08.2349

Hauber AB, Nguyen H, Posner JD, Ervin CM, LaRue S, Kalsekar I. Patient preferences for frequency of glucagon-like peptide-1 receptor agonist (glp-1ra) injections in the treatment of type 2 diabetes. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 4, 2014. [abstract] Value Health. 2014 May; 17(3):A255.

Schwab PE, Saundankar V, Bouchard J, Moretz C, Baltz J. Delayed treatment modifications for patients with type 2 diabetes mellitus with very poor glycemic control. Poster presented at the 2014 ISPOR 19th Annual International Meeting; May 31, 2014. Montreal, Canada. [abstract] Value Health. 2014 May; 17(3).

Bhattacharyya S, Sacco P, Shirore R, Sonathi V, Thomas SK. A de novo economic model to assess the cost and quality of life consequences of an intervention for levodopa induced dyskinesia amongst patients with Parkinson's disease. Poster presented at the 2013 ISPOR 16th Annual European Congress; November 2013. Dublin, Ireland. [abstract] Value Health. 2013 Nov; 16(7):A590-1.

Xe Y, Bays H, Schwab PE, Louder A. Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 18, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A295. doi: 10.1016/j.jval.2013.03.1529

Yuan Z, Levitan B, Burton P, Poulos C, Hauber AB, Berlin J. Relative importance of benefits and risks associated with antithrombotic therapies of acute coronary syndrome: patient and physician perspectives. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A292-3.